But if the contract states there are no competing customers, and talks about 4 different sites, I'd say most bases should have been covered.
But does the AZ-EU Advance Purchase Agreement[1], which is the somewhat redacted document that was published, talk about 4 different sites? I haven't found anything about specific sites so far, nor any guarantee that there are no competing customers. Have I missed something?
In section 5.1, it does state that AZ shall use its BREs to manufacturer the Initial European Doses within the EU. Then in section 5.4, it states that AZ shall use its BREs to manufacture the Vaccine at manufacturing sites located within the EU, and that specifically for section 5.4 only, that includes the UK. If the exception proves the rule, those sections together appear to imply that AZ must try to manufacture those initial batches for the EU within the EU not including the UK, and then any subsequent manufacture can be done in either the EU or UK (and otherwise there are some additional provisions about other possibilities). Maybe a lawyer can comment on the choice of language there, but it seems awkwardly written to me.
But does the AZ-EU Advance Purchase Agreement[1], which is the somewhat redacted document that was published, talk about 4 different sites? I haven't found anything about specific sites so far, nor any guarantee that there are no competing customers. Have I missed something?
In section 5.1, it does state that AZ shall use its BREs to manufacturer the Initial European Doses within the EU. Then in section 5.4, it states that AZ shall use its BREs to manufacture the Vaccine at manufacturing sites located within the EU, and that specifically for section 5.4 only, that includes the UK. If the exception proves the rule, those sections together appear to imply that AZ must try to manufacture those initial batches for the EU within the EU not including the UK, and then any subsequent manufacture can be done in either the EU or UK (and otherwise there are some additional provisions about other possibilities). Maybe a lawyer can comment on the choice of language there, but it seems awkwardly written to me.
[1] https://www.rai.it/dl/doc/2021/02/19/1613725900577_AZ_FIRMAT...